Top

Current Oncology Reports

Published in:

01-07-2007

Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?

Authors: Rosalyn Juergens, MD, Julie Brahmer, MD, MSc

Published in: Current Oncology Reports | Issue 4/2007

Title: Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?
Authors: Rosalyn Juergens, MD
Julie Brahmer, MD, MSc
Publication date: 01-07-2007
Publisher: Current Science Inc.
Published in: Current Oncology Reports / Issue 4/2007
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI: https://doi.org/10.1007/s11912-007-0031-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2007

Clinical trials report

Lung cancer screening

Cancer-related constipation

Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor

Sarcoma molecular testing: Diagnosis and prognosis

Chemotherapy-induced neuropathy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer